CHINA MEDICAL & HEALTHCARE GROUP LIMITED Financials China Medical & HealthCare Group Limited
Equities
383
BMG2133H2006
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.68 HKD | 0.00% |
|
0.00% | -15.00% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,867 | 2,259 | 1,694 | 999.1 | 796.4 | 868.8 |
| Enterprise Value (EV) 1 | 2,999 | 2,409 | 2,047 | 1,389 | 1,186 | 776.9 |
| P/E ratio | -20.8 x | 1,560 x | -15.1 x | -7.28 x | -6.44 x | 65.4 x |
| Yield | - | - | - | - | - | 1.25% |
| Capitalization / Revenue | 2.6 x | 1.84 x | 1.42 x | 0.68 x | 0.55 x | 0.55 x |
| EV / Revenue | 2.72 x | 1.96 x | 1.71 x | 0.95 x | 0.82 x | 0.5 x |
| EV / EBITDA | 95.9 x | 23.2 x | 20.2 x | 16 x | 17.1 x | 5.45 x |
| EV / FCF | 13.2 x | - | 229 x | 55.8 x | -4.21 x | 6.03 x |
| FCF Yield | 7.56% | - | 0.44% | 1.79% | -23.7% | 16.6% |
| Price to Book | 1.6 x | 1.25 x | 0.95 x | 0.59 x | 0.51 x | 0.46 x |
| Nbr of stocks (in thousands) | 724,004 | 724,004 | 724,004 | 724,004 | 724,004 | 1,086,005 |
| Reference price 2 | 3.960 | 3.120 | 2.340 | 1.380 | 1.100 | 0.8000 |
| Announcement Date | 10/30/18 | 4/28/20 | 4/29/21 | 4/28/22 | 4/27/23 | 4/16/24 |
1HKD in Million2HKD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,101 | 1,228 | 1,194 | 1,463 | 1,438 | 1,569 |
| EBITDA 1 | 31.28 | 103.8 | 101.1 | 86.73 | 69.43 | 142.5 |
| EBIT 1 | -74.79 | -1.395 | -7.351 | -11.69 | -24.86 | 53.4 |
| Operating Margin | -6.8% | -0.11% | -0.62% | -0.8% | -1.73% | 3.4% |
| Earnings before Tax (EBT) 1 | -133.4 | -19.21 | -96.56 | -110.5 | -117.2 | 35.4 |
| Net income 1 | -137.1 | 1.451 | -111.9 | -137.3 | -123.6 | 11.3 |
| Net margin | -12.46% | 0.12% | -9.37% | -9.38% | -8.59% | 0.72% |
| EPS 2 | -0.1900 | 0.002000 | -0.1546 | -0.1896 | -0.1707 | 0.0122 |
| Free Cash Flow 1 | 226.9 | - | 8.951 | 24.89 | -281.5 | 128.8 |
| FCF margin | 20.61% | - | 0.75% | 1.7% | -19.58% | 8.21% |
| FCF Conversion (EBITDA) | 725.19% | - | 8.85% | 28.7% | - | 90.36% |
| FCF Conversion (Net income) | - | - | - | - | - | 1,140% |
| Dividend per Share | - | - | - | - | - | 0.0100 |
| Announcement Date | 10/30/18 | 4/28/20 | 4/29/21 | 4/28/22 | 4/27/23 | 4/16/24 |
1HKD in Million2HKD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 132 | 150 | 352 | 390 | 390 | - |
| Net Cash position 1 | - | - | - | - | - | 91.9 |
| Leverage (Debt/EBITDA) | 4.222 x | 1.449 x | 3.485 x | 4.501 x | 5.612 x | - |
| Free Cash Flow 1 | 227 | - | 8.95 | 24.9 | -281 | 129 |
| ROE (net income / shareholders' equity) | -7.66% | - | -5.82% | -7.24% | -7.23% | 1.17% |
| ROA (Net income/ Total Assets) | -1.14% | - | -0.14% | -0.21% | -0.46% | 0.97% |
| Assets 1 | 12,055 | - | 81,999 | 64,977 | 26,730 | 1,159 |
| Book Value Per Share 2 | 2.480 | 2.490 | 2.470 | 2.350 | 2.150 | 1.720 |
| Cash Flow per Share 2 | 0.7500 | 0.8900 | 0.8500 | 0.8000 | 0.8100 | 0.8200 |
| Capex 1 | 60 | 95.7 | 100 | 154 | 138 | 196 |
| Capex / Sales | 5.45% | 7.8% | 8.41% | 10.55% | 9.6% | 12.48% |
| Announcement Date | 10/30/18 | 4/28/20 | 4/29/21 | 4/28/22 | 4/27/23 | 4/16/24 |
1HKD in Million2HKD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -15.00% | 94.34M | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +9.72% | 10.79B | |
| +23.61% | 8.26B | |
| -2.19% | 7.68B | |
| +20.75% | 7.2B | |
| +4.49% | 6.67B | |
| +50.89% | 4.66B |
- Stock Market
- Equities
- 383 Stock
- Financials China Medical & HealthCare Group Limited
